Eswatini vs Kazakhstan: Previously treated cases tested for RR-/MDR-TB
Eswatini
100.0%
in 2024
Kazakhstan
100.0%
in 2024
Eswatini rank
1st
Kazakhstan rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Eswatini
- Kazakhstan
How they compare
Eswatini currently reports 100.0% against 100.0% in Kazakhstan, a difference of 0.0%.
The two have swapped places 4 times across 14 shared years of data; in 2007 it was Kazakhstan ahead.
Eswatini ranks 1st and Kazakhstan ranks 1st of 180 countries.
Across the 3 decades both report, Eswatini averaged higher in 1 and Kazakhstan in 1.
Head to head by decade
| Decade | Eswatini | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 52.0% | 50.5% | 1.5% | Eswatini |
| 2010s | 63.3% | 84.9% | 21.6% | Kazakhstan |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Eswatini or Kazakhstan?
- Eswatini, at 100.0% against 100.0% in Kazakhstan as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Eswatini and Kazakhstan?
- 0.0%, with Eswatini ahead.
- How many years of comparable data are there for Eswatini and Kazakhstan?
- 14 years are reported by both, from 2007 to 2024.
- How do Eswatini and Kazakhstan rank globally for previously treated cases tested for rr-/mdr-tb?
- Eswatini ranks 1st and Kazakhstan ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.